NeuroOne Overview

NeuroOne Medical Technologies Incorporated (Ticker: NMTC) is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, initially targeting epilepsy. We are currently focused on the development and commercialization of patented thin-film electrode technology for electrocorticography (ECoG) and stereoelectroencephalography (sEEG) recording of brain activity.

Corporate Presentation

Intelectual Property

Wisconsin Alumni Research Foundation

Our patent estate consists of three issued U.S. patents licensed from The Wisconsin Alumni Research Foundation (WARF) covering a neural probe array and thin-film micro electrode array and method. The licensed issued patents expire between 2025 and 2030, subject to any patent extensions that may be available.

  • U.S. Patent No. 8,483,794 (Neural probe array)

  • U.S. Patent No. 8,386,007 (Thin-film micro electrode array and method)

  • U.S. Patent No. 7,774,053 (Method for implanting an electrode)

NeuroOne

NeuroOne converted two provisional patents to a patent application that was published on October 11, 2018 relating to a wide variety of concepts, ranging from accessories for brain surgery to ablation and stimulation concepts for both cortical and depth electrodes. We also recently filed a new provisional patent for the delivery of drugs using our electrodes.

  • Provisional Patent Filed on March 31, 2017

  • Provisional Patent Filed on October 26, 2017